NCT02530541View on ClinicalTrials.gov

Antimicrobial Efficacy of 2% CHG (Chlorhexidine Gluconate)

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

33

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

July 31, 2014

Study Completion Date

May 31, 2015

Conditions

Healthy

Interventions

DRUG

CHG

Varied application times

Sponsors

Lead Sponsor

Medline Industries

All Listed Sponsors

lead

Medline Industries

INDUSTRY

NCT02530541 - Antimicrobial Efficacy of 2% CHG (Chlorhexidine Gluconate) | Biotech Hunter | Biotech Hunter